~~<i id='E9A76D1A8E'><strike id='E9A76D1A8E'><tt id='E9A76D1A8E'><pre id='E9A76D1A8E'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：leisure time 2025-10-02 21:53:42 Page View：58

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Former medical device CEO who sold dummy, plastic parts convicted of fraud
Next article： Trump demands the U.S. pay no more for drugs than other countries … again

Wikipedia

ChatGPT in medicine: STAT answers readers' burning questions

MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

U.K. sequencing study surfaces new findings about tumor DNA

AdobeLONDON—Adecadeago,theU.K.launchedits100,000GenomesProject,amajorresearchendeavorthatinvolvedseq

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

The Readout: Amylyx, Alumis, and Lundbeck drug updates

AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

WSS

hotspot

hotspot

knowledge

Wikipedia

The Readout: Amylyx, Alumis, and Lundbeck drug updates